Got a stuffy nose and a cough? If you go to an urgent care or ER, chances are that you may be able find out exactly what type of germ is making you sick, thanks to newer tests that don’t look for just ...
Please provide your email address to receive an email when new articles are posted on . “Contrary to the initial intentions of the multiplex assay, our study demonstrates that the inherent advantages ...
DENVER, Jan. 15, 2026 /PRNewswire/ -- QuantiPath, a molecular diagnostics company advancing pathogen detection and food safety innovation, today announced a significant expansion of its molecular ...
The "Molecular Diagnostics for Infectious Disease – Market Forecasts, Strategies and Trends – By Syndrome and by Country – With Multiplex and Point of Care Market Analysis, Executive Guides and ...
Claims for unregulated rapid molecular diagnostic tests for urinary tract infections (UTIs) in older adults have soared 60-fold from 2016 to 2023, according to Medicare data. The rise was most ...
Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer Although predictive multiplex somatic ...
The diagnostics advisory committee reviewed the evidence available on the clinical and cost effectiveness of using multiplex allergen testing, in combination with standard clinical assessment, to help ...
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results